Evidence map›Paper›PMID 41757222›Full record

ReviewThe Lancet regional health. Europe2026

Inequitable access to medicines for neglected tropical diseases in Europe: health system vulnerabilities and a call for coordinated action.

Raffaella Ravinetto, Emmanuel Bottieau, Daniela Fusco, Rosalia Marrone, Steven Van Den Broucke, Maria-Belen Tarrafeta-Sayas, Laura Rinaldi, Irene Losada-Galván, Guido Calleri, Marco Albonico

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raffaella RavinettoDepartment of Public Health, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.
Emmanuel BottieauDepartment of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.
Daniela FuscoImplementation Research Group, Bernhard-Nocht Institute for Tropical Medicine, Bernard Nocht Strasse 74, 20359, Hamburg, Germany.
Rosalia MarroneNational Institute for Health, Migration and Poverty (NIHMP), via di san Gallicano 25/a, 00153, Rome, Italy.
Steven Van Den BrouckeDepartment of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.
Maria-Belen Tarrafeta-SayasDepartment of Public Health, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.
Laura RinaldiWHO Collaborating Centre for the Diagnosis of Intestinal Helminths and Protozoa, University Federico II, Via F. Delpino 1, 80137, Naples, Italy.
Irene Losada-GalvánISGlobal, C/ Rosselló, 132, 08036, Barcelona, Spain.
Guido CalleriNational Health System, Torino, Azienda Sanitaria Locale TO2, Ospedale Amedeo di Savoia, 164 Corso Svizzera, 10149, Torino, TO, Italy.
Marco AlbonicoNational Health System, Torino, Azienda Sanitaria Locale TO2, Ospedale Amedeo di Savoia, 164 Corso Svizzera, 10149, Torino, TO, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has exposed the vulnerability of the European medicine supply systems, but the lack of access to medicines for diseases of poverty, including neglected tropical diseases (NTDs), is unfrequently brought to the attention of the European policy makers. As a result, clinicians in Europe are forced to "bricolage solutions" to treat NTDs:

Indexed as

AccessEquityEssential medicinesEuropeHealth systemsInfectious diseasesNeglected tropical diseasesPublic health

Identifiers

PMID41757222
PMCPMC12934290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.